Posted on

epidiolex success rate

Researchers in this study reviewed the main findings of these trials regarding the safety, efficacy, and tolerability of Epidiolex for the treatment of children with Dravet and Lennox-Gastaut syndromes.

According to the researchers, the EAP trial was the first to present preliminary evidence suggesting “CBD’s positive effect in reducing seizure frequency and tolerable safety profile.”

GW Pharmaceuticals‘ Epidiolex, the first plant-derived cannabidiol medication to be approved by the U.S. Food and Drug Administration, is effective in significantly reducing the frequency of epileptic seizures as an adjunct therapy in children with Dravet syndrome and Lennox-Gastaut syndrome, a review study shows.

“The frequency and severity of seizures have profound impacts on quality of life, risk for injury (eg, convulsive seizures in [Dravet syndrome], drop seizures in [Lennox-Gastaut syndrome]), health care use, and increased risk for mortality,” the researchers wrote.

Marketed by Greenwich Biosciences, a subsidiary company of GW Pharmaceuticals, Epidiolex is a purified liquid formulation of plant-derived cannabis that is supplied as a 100-mg/mL strawberry-flavored oral solution in a sesame oil base.

Learn more about CBD, and download a doctor discussion guide and other helpful tools and worksheets, including dosing and medication schedules.

What is EPIDIOLEX (cannabidiol)?

Ready

What is the Most Important Information I Should Know About EPIDIOLEX (cannabidiol)?

What Additional Information Applies to Women?

Words any mother would love to hear, but for Jen, they mean even more. Because for years, her son Cameron’s frequent seizures made it difficult for him to interact with his family.